Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Sarcoma, Kaposi 4Sarcoma 3Stomach Neoplasms 1Skin Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liposarcoma 1Hodgkin Disease 1HIV Infections 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Castleman Disease 1AIDS-related Kaposi sarcoma 1AIDS-Related Opportunistic Infections 1

Interventions

Doxorubicin 11Zidovudine 9Vincristine 8Bleomycin 7Liposomes 5Interferon alpha-2 5tecogalan 4Etoposide 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3sargramostim 2interferon alfa-n1 2Semaxinib 2Rituximab 2Ritonavir 2Polymerase Chain Reaction 2Nivolumab 2Mitoxantrone 2Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 2Didanosine 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1nirogacestat 1fludarabine phosphate 1emvododstat 1efineptakin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Nelfinavir × Sarcoma × Clear all
NCT00002185 2005-06-24

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
20 enrolled
DermatologicSarcoma

Sarcoma, Kaposi, Skin Neoplasms, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡